BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Dec 19, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Injectafer regulatory update

Daiichi's Luitpold Pharmaceuticals Inc. unit said FDA assigned a PDUFA date of Aug. 3, 2012, for an NDA for Injectafer ferric carboxymaltose to treat iron deficiency anemia....

Read the full 113 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >